HK Stock MarketDetailed Quotes
02633 JACOBSON PHARMA
- 0.820
- +0.020+2.50%
Closing Auction Session Nov 27 15:46 CST
1.64BMarket Cap6.46P/E (TTM)
0.820High0.790Low3.08MVolume0.790Open0.800Pre Close2.48MTurnover0.15%Turnover Ratio6.17P/E (Static)2.00BShares0.84052wk High0.67P/B1.64BFloat Cap0.51052wk Low0.05Dividend TTM2.00BShs Float1.969Historical High0.054Dividend LFY3.75%Amplitude0.301Historical Low0.805Avg Price2000Lot Size6.59%Div YieldTTM6.59%Div Yield LFY
JACOBSON PHARMA Key Stats
All
YOY
| (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 13.30%810M | 15.79%1.47B | 22.86%714.92M | -20.55%1.27B | -22.46%581.89M | 10.35%1.6B | 7.91%750.41M | -7.99%1.45B | -8.16%695.43M | -7.81%1.57B |
| Operating income | 13.30%810M | 15.79%1.47B | 22.86%714.92M | -20.55%1.27B | -22.46%581.89M | 10.35%1.6B | 7.91%750.41M | -7.99%1.45B | -8.16%695.43M | -7.81%1.57B |
| Cost of sales | -10.80%-458.53M | -16.28%-847.32M | -26.14%-413.84M | 25.27%-728.68M | 31.30%-328.08M | -10.19%-975.02M | -11.28%-477.57M | -0.38%-884.83M | -5.56%-429.17M | 13.13%-881.48M |
| Operating expenses | -10.80%-458.53M | -16.28%-847.32M | -26.14%-413.84M | 25.27%-728.68M | 31.30%-328.08M | -10.19%-975.02M | -11.28%-477.57M | -0.38%-884.83M | -5.56%-429.17M | 13.13%-881.48M |
| Gross profit | 16.74%351.47M | 15.13%620.48M | 18.62%301.08M | -13.15%538.92M | -6.98%253.81M | 10.59%620.52M | 2.47%272.84M | -18.68%561.08M | -24.07%266.26M | 0.01%689.98M |
| Selling expenses | 2.55%-63.13M | -7.61%-128.69M | -19.09%-64.78M | 35.04%-119.59M | 38.60%-54.39M | -3.76%-184.09M | 3.42%-88.59M | 9.15%-177.41M | 0.51%-91.73M | -9.90%-195.29M |
| Administrative expenses | -4.41%-102.13M | -14.22%-203.69M | -25.53%-97.82M | 17.46%-178.33M | 17.08%-77.93M | 6.14%-216.05M | 4.83%-93.98M | -11.43%-230.17M | -1.31%-98.75M | -19.33%-206.57M |
| Special items of operating profit | -65.22%9.56M | -37.80%45.03M | -34.25%27.49M | 78.74%72.39M | 57.18%41.81M | -60.58%40.5M | -62.56%26.6M | 241.44%102.74M | 195.27%71.05M | -19.73%30.09M |
| Operating profit | 17.96%195.78M | 6.30%333.13M | 1.64%165.97M | 20.12%313.38M | 39.72%163.3M | 1.81%260.89M | -20.40%116.87M | -19.48%256.24M | -20.65%146.83M | -15.50%318.22M |
| Financing cost | 56.73%-20.53M | -28.16%-78.71M | -142.23%-47.45M | -139.08%-61.41M | -52.25%-19.59M | 14.79%-25.69M | 18.06%-12.87M | 45.55%-30.14M | 48.38%-15.7M | 16.37%-55.36M |
| Share of profits of associates | -61.14%129K | 110.14%165K | 133.77%332K | 54.23%-1.63M | 45.84%-983K | 3.29%-3.56M | -17.32%-1.82M | -284.45%-3.68M | -152.89%-1.55M | -57.77%1.99M |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | 88.49%-213K | 83.85%-285K | -35.60%-1.85M | ---1.77M | ---1.37M |
| Earning before tax | 47.55%175.38M | 1.69%254.58M | -16.72%118.86M | 8.17%250.35M | 40.06%142.73M | 4.93%231.43M | -20.27%101.91M | -16.29%220.57M | -18.88%127.81M | -16.38%263.49M |
| Tax | -62.60%-35.09M | -3.35%-44.41M | 9.50%-21.58M | 1.72%-42.98M | -25.19%-23.84M | -27.62%-43.73M | -23.98%-19.05M | 25.55%-34.26M | 44.71%-15.36M | 18.41%-46.03M |
| After-tax profit from continuing operations | 44.21%140.29M | 1.35%210.17M | -18.17%97.28M | 10.48%207.37M | 43.48%118.88M | 0.75%187.71M | -26.31%82.86M | -14.33%186.31M | -13.35%112.45M | -15.93%217.46M |
| After-tax profit from non-continuing business | ---- | 6.29%80.61M | 182.98%80.61M | --75.84M | --28.49M | ---- | ---- | -99.82%3K | -99.86%3K | --1.65M |
| Earning after tax | -21.14%140.29M | 2.67%290.78M | 20.71%177.89M | 50.88%283.21M | 77.85%147.37M | 0.75%187.71M | -26.32%82.86M | -14.97%186.31M | -14.73%112.45M | -15.30%219.11M |
| Minority profit | ---- | -25.98%23.81M | 113.40%23.85M | 220.40%32.17M | 296.31%11.18M | -20.29%10.04M | -71.63%2.82M | 262.24%12.6M | 113.26%9.94M | -57.16%3.48M |
| Shareholders should account for profits from continuing business | 44.17%140.29M | 1.31%210.24M | -9.65%97.31M | --207.51M | --107.71M | ---- | ---- | -19.01%173.71M | -18.48%102.51M | --214.49M |
| Shareholders should account for profits from non-continuing business | ---- | 30.33%56.73M | 99.16%56.73M | --43.53M | --28.49M | ---- | ---- | -99.74%3K | -99.80%3K | --1.14M |
| Profit attributable to shareholders | -8.93%140.29M | 6.34%266.97M | 13.11%154.04M | 41.30%251.04M | 70.16%136.19M | 2.28%177.67M | -21.92%80.04M | -19.44%173.71M | -19.42%102.51M | -13.94%215.63M |
| Basic earnings per share | -12.28%0.0707 | 5.86%0.139 | 13.52%0.0806 | 41.64%0.1313 | 69.86%0.071 | 2.21%0.0927 | -21.87%0.0418 | -16.56%0.0907 | -15.35%0.0535 | -16.26%0.1087 |
| Diluted earnings per share | -12.28%0.0707 | 5.86%0.139 | 13.52%0.0806 | 41.64%0.1313 | 69.86%0.071 | 2.21%0.0927 | -21.87%0.0418 | -16.56%0.0907 | -15.35%0.0535 | -16.26%0.1087 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data